Breaking News Instant updates and real-time market news.

2019-11-26 06:05:36 DY Dycom $50.01 2.255 (4.72%) 06:05 11/26/19 11/26 06:05 11/26/19 06:05	Dycom sees Q4 adj. EPS (15c)-2c, consensus 10c Sees Q4 contract revenue $700M-$740M, consensus $747.28M.	26 Nov 03 Dec
DY Dycom $50.01 2.255 (4.72%) 05/22/19 DBAB 05/22/19 NO CHANGE Target $62 DBAB Buy Dycom price target raised to $62 from $54 at Deutsche Bank Deutsche Bank anlayst Chad Dillard raised his price target for Dycom Industries to $62 from $54 saying the company reported "sound" Q1 results against low expectations. The analyst believes the "story is intact" and keeps a Buy rating on Dycom. 05/22/19 WELS 05/22/19 NO CHANGE Target $63 WELS Outperform Dycom price target raised to $63 from $50 at Wells Fargo Wells Fargo analyst Jennifer Fritzsche raised his price target for Dycom to $63 from $50 after the company posted "strong" Q1 results, particularly from a top-line perspective, due to "significant growth" from four of its top five customers. Ultimately, the analyst believes Dycom can deliver double-digit earnings and EBITDA growth in 2021 after working through the near-term cost headwinds, but would remain slightly more cautious in the near-term based on the current valuation and the expectation for decelerating revenue growth and negative earnings/EBITDA growth through 2020. He reiterates an Outperform rating on the shares. 05/22/19 CHLM 05/22/19 NO CHANGE Target $65 CHLM Buy Dycom price target raised to $65 from $51 at Craig-Hallum Craig-Hallum analyst Christian Schwab raised his price target for Dycom to $65 from $51 following better than expected Q1 results and in-line guidance. The analyst believes after roughly a year and a half of challenging execution and "disappointing results" that estimate cuts are now behind the company. He reiterates a Buy rating on the shares. 09/17/19 WELS 09/17/19 NO CHANGE Target $61 WELS Outperform Dycom price target raised to $61 from $52 at Wells Fargo Wells Fargo analyst Jennifer Fritzsche raised her price target for Dycom to $61 from $52 after meeting with management and coming away favoring the setup of the stock for the remainder of the year. While Dycom still continues to work on improve the economics of the large customer project, demand for its services exists from a broad range of customer segments, she contends. As the traditional wireless and wireline capex lines continue to get more blurred, the analyst remains encouraged Dycom can play a key role in the 5G infrastructure landscape. Fritzsche reiterates an Outperform rating on the shares.

2019-11-26 06:05:36

Dycom

$50.01: 2.255 (4.72%)

06:05

11/26/19

11/26

06:05

11/26/19

06:05

Dycom sees Q4 adj. EPS (15c)-2c, consensus 10c

Sees Q4 contract revenue $700M-$740M, consensus $747.28M.

26
Nov
03
Dec

DY Dycom

$50.01: 2.255 (4.72%)

05/22/19: DBAB

05/22/19: WELS

05/22/19: CHLM

09/17/19: WELS

TODAY'S FREE FLY STORIES

CCJ Cameco $9.15 -0.625 (-6.39%) 15:45 12/09/19 12/09 15:45 12/09/19 15:45 Options	Cameco call volume above normal and directionally bullish » Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
SNAP Snap $14.33 -0.415 (-2.82%) 15:42 12/09/19 12/09 15:42 12/09/19 15:42 Periodicals	Snapchat feature to allow users to 'deepfake you into GIFs,' Tech Crunch says » Tech Crunch's Josh… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
TSLA Tesla $342.06 6.21 (1.85%) 15:35 12/09/19 12/09 15:35 12/09/19 15:35 Hot Stocks	Senator Markey says Tesla Autopilot 'can't be allowed' to replace drivers » U.S. Senator Ed Markey, a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	10 Dec 07 Jan
CASY Casey's General Stores $175.80 (0.00%) 15:34 12/09/19 12/09 15:34 12/09/19 15:34 Options	Caseys General Stores options imply 8.0% move in share price post-earnings » Pre-earnings options… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	10 Dec
MSFT Microsoft $151.60 -0.17 (-0.11%) 15:33 12/09/19 12/09 15:33 12/09/19 15:33 Hot Stocks	Microsoft to shut down Wunderlist on May 6, 2020 » Microsoft said in a blog… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	09 Dec

AQST Aquestive Therapeutics $7.89 -0.13 (-1.62%) 15:25 12/09/19 12/09 15:25 12/09/19 15:25 Conference/Events	Aquestive Therapeutics holds analyst & investor event w/conference call hookup » Management and Key… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	09 Dec 09 Dec
PTLA Portola Pharmaceuticals $28.48 -0.74 (-2.53%) 15:24 12/09/19 12/09 15:24 12/09/19 15:24 Hot Stocks	Portola presents new interim Phase 2a data from study of cerdulatinib » Portola Pharmaceuticals… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
ARQL ArQule $19.72 10.045 (103.88%) 15:21 12/09/19 12/09 15:21 12/09/19 15:21 Downgrade	ArQule rating change » ArQule downgraded to Hold… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	09 Dec 09 Dec 09 Dec 09 Dec
TOL Toll Brothers $41.50 0.62 (1.52%) 15:19 12/09/19 12/09 15:19 12/09/19 15:19 Options	Toll Brothers options imply 8.6% move in share price post-earnings » Pre-earnings options… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	10 Dec
$NSD NASDAQ Market Internals $0.00 (0.00%) 15:17 12/09/19 12/09 15:17 12/09/19 15:17 Technical Analysis	NASDAQ market internals summary » Volume is average for… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

$NYE NYSE Market Internals $0.00 (0.00%) 15:16 12/09/19 12/09 15:16 12/09/19 15:16 Technical Analysis	NYSE market internals summary » Volume is below average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
DISH Dish $33.53 -0.06 (-0.18%) 15:15 12/09/19 12/09 15:15 12/09/19 15:15 Options	Dish put volume heavy and directionally bearish » Bearish flow noted in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
MGNX MacroGenics $9.87 0.19 (1.96%) 15:09 12/09/19 12/09 15:09 12/09/19 15:09 Hot Stocks	MacroGenics announces updated results from Phase 1/2 study of flotetuzumab » MacroGenics announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	09 Dec
MDB MongoDB $131.13 -0.09 (-0.07%) 15:04 12/09/19 12/09 15:04 12/09/19 15:04 Options	MongoDB options imply 14.8% move in share price post-earnings » Pre-earnings options… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	09 Dec 09 Dec 18 Dec
IMGN ImmunoGen $4.06 0.195 (5.05%) 15:03 12/09/19 12/09 15:03 12/09/19 15:03 Hot Stocks	ImmunoGen presents updated findings from Phase 1 study of IMGN632 at ASH meeting » ImmunoGen announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

15:00 12/09/19 12/09 15:00 12/09/19 15:00 General news	U.S.-China trade/tariff uncertainty is still present » U.S.-China trade/tariff… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial
NVS Novartis $92.68 0.6 (0.65%) 14:53 12/09/19 12/09 14:53 12/09/19 14:53 Hot Stocks	Novartis says Kymriah demonstrates consistent efficacy, safety outcomes » Novartis announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	09 Dec
GILD Gilead $67.11 0.02 (0.03%) 14:51 12/09/19 12/09 14:51 12/09/19 14:51 Hot Stocks	Gilead's Kite says results ZUMA-2 trial support regulatory filings » Kite, a Gilead company,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
GMDA Gamida Cell $5.10 0.01 (0.20%) 14:49 12/09/19 12/09 14:49 12/09/19 14:49 Hot Stocks	Gamida Cell announces results from Phase 1 clinical study of GDA-201 » Gamida Cell announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
SFIX Stitch Fix $25.05 0.92 (3.81%) 14:49 12/09/19 12/09 14:49 12/09/19 14:49 Options	Stitch Fix options imply 24.0% move in share price post-earnings » Pre-earnings options… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	09 Dec 11 Dec 12 Dec 19 Dec

GILD Gilead $67.08 -0.01 (-0.01%) 14:47 12/09/19 12/09 14:47 12/09/19 14:47 Hot Stocks	Gilead's Kite announces findings from ongoing post-marketing study of Yescarta » Kite, a Gilead company,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
NUAN Nuance $17.55 -0.34 (-1.90%) 14:45 12/09/19 12/09 14:45 12/09/19 14:45 Options	Nuance call volume above normal and directionally bullish » Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	10 Dec
GS Goldman Sachs $222.17 -2.4 (-1.07%) , SFTBF SoftBank $0.00 (0.00%) … 14:41 12/09/19 12/09 14:41 12/09/19 14:41 Periodicals	SoftBank taps Goldman for $1.75B financing to help revive WeWork, Bloomberg says » SoftBank (SFTBF) has… GS Goldman Sachs $222.17 -2.4 (-1.07%) SFTBF SoftBank $0.00 (0.00%) WE We Company $0.00 (0.00%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	15 Jan 26 Feb
CBL CBL & Associates $1.12 -0.025 (-2.18%) 14:36 12/09/19 12/09 14:36 12/09/19 14:36 Hot Stocks	CBL & Associates closes sale of interest in the Outlet Shoppes at Atlanta » CBL Properties announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	07 Feb
14:25 12/09/19 12/09 14:25 12/09/19 14:25 Options	Berkshire Hathaway call volume above normal and directionally bullish » Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial

Events

Earnings calls, analyst events, roadshows and more

AQST
Today at 16:00

Aquestive Therapeutics - AQST Conference Calls
AQST
Today at 16:00

Aquestive Therapeutics, Inc. Firm Sponsored Meetings
CDMO
Today at 16:30

Avid Bioservices - CDMO Conference Calls
ASNA
Today at 16:30

Ascena Retail - ASNA Conference Calls
GNSS
Today at 16:30

Genasys - GNSS Conference Calls
LAKE
Today at 16:30

Lakeland Industries - LAKE Conference Calls
MDB
Today at 17:00

MongoDB - MDB Conference Calls
MTN
Today at 17:00

Vail Resorts - MTN Conference Calls
CHWY
Today at 17:00

Chewy - CHWY Conference Calls
SFIX
Today at 17:00

Stitch Fix - SFIX Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	CRWD X CRWD Crowdstrike Block Trade Managers: Goldman Sachs $50.89 2.2M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AUPH X AUPH Aurinia Pharmaceuticals Secondary Managers: Jefferies & SVB Leerink, H.C. Wainwright, Oppenheimer, Bloom Burton $15.44 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	XP X XP XP IPO Managers: Goldman Sachs, JPMorgan, Morgan Stanley, XP & Itau BBA, BofA/Merrill, Citi, Credit Suisse, UBS $22.00-25.00 72.511M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	BILL X BILL Bill.com IPO Managers: Goldman Sachs, BofA/Merrill, Jefferies & KeyBanc, Canaccord, Needham, William Blair $16.00-18.00 8.824M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EH X EH Ehang IPO Managers: Morgan Stanley, Needham, Tigress Financial, Prime Number $12.50-14.50 3.2M Shares MNRL X MNRL Brigham Minerals Secondary Managers: Credit Suisse, Goldman Sachs & RBC Capital $19.70 11M Shares
Thurs	OCFT X OCFT OneConnect IPO Managers: Morgan Stanley, Goldman Sachs, JPMorgan & Ping An of China, BofA/Merrill, HSBC, CLSA, KeyBanc $12.00-14.00 36M Shares SPT X SPT Sprout Social IPO Managers: Goldman Sachs, Morgan Stanley, KeyBanc & William Blair, Canaccord, Stifel $16.00-18.00 8.824M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Dycom sees Q4 adj. EPS (15c)-2c, consensus 10c

TODAY'S FREE FLY STORIES

Get Full Fly Access